Literature DB >> 10332713

Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.

J L Kitzmiller, E Main, B Ward, T Theiss, D L Peterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10332713     DOI： 10.2337/diacare.22.5.874

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  7 in total

Review 1.  Insulin analogues in the management of the pregnancy complicated by diabetes mellitus.

Authors:  Celeste P Durnwald; Mark B Landon
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

Review 2.  The utility and efficacy of the new insulins in the management of diabetes and pregnancy.

Authors:  David Simmons
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 3.  Diabetic macular edema: correlations with available diabetes therapies--evidence across a qualitative review of published literature from MEDLINE and EMBASE.

Authors:  Domenico Merante; Francesca Menchini; Kenneth E Truitt; Francesco M Bandello
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

Review 4.  Does pregnancy accelerate the rate of progression of diabetic retinopathy?

Authors:  Bhavna P Sheth
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 5.  Does pregnancy accelerate the rate of progression of diabetic retinopathy?: an update.

Authors:  Bhavna P Sheth
Journal:  Curr Diab Rep       Date:  2008-08       Impact factor: 4.810

Review 6.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

7.  When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study.

Authors:  H C Jang; S Guler; M Shestakova
Journal:  Int J Clin Pract       Date:  2008-05-09       Impact factor: 2.503
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.